ARIAD Pharmaceuticals Inc.

ARIAD to Present at the Oppenheimer 20th Annual Healthcare Conference.(Conference news)
Cancer Weekly; 11/10/2009; 855 words; ...Clinical Trials, Oncology, Pharmaceutical, Technology, Ariad Pharmaceuticals Inc., Cancer, Oncology, Pharmaceutical Business, Pharmaceutical Company, ARIAD Pharmaceuticals Inc. This article was prepared...

ARIAD Reports Third Quarter 2009 Development Progress and Financial Results.(Financial report)
Business Wire; 11/5/2009; 2048 words; ...at ASH CAMBRIDGE, Mass. -- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported...Enrollment Expected at Year-End ARIAD reaffirmed that the global, Phase...ridaforolimus partner, Merck & Co., Inc., are making steady progress...

Conference Calls Today: 8-8:45 A.M. EDT.
Investrend; 11/5/2009; 1254 words; ...NASDAQ: ESLR), Cardinal Health Inc. (NYSE: CAH), Paetec Corp...NASDAQ: GTSI), Eagle Food Centers Inc. (NASDAQ: EGLE), Target Corporation...Corporation (NASDAQ: INCY), Ariad Pharmaceuticals Inc. (NASDAQ: ARIA), 3M Company...

Ariad's AP24534 Featured in Cancer Cell Publication.
Health & Beauty Close-Up; 11/5/2009; 920 words; Ariad Pharmaceuticals, Inc. announced that the scientific journal...preclinical characterization of AP24534, Ariad's investigational, multi-targeted...is co-authored by scientists from Ariad, and collaborating investigators from...

Other News To Note.
BIOWORLD Today; 11/4/2009; 1686 words; ...financial terms were not disclosed. o Ariad Pharmaceuticals Inc., of Cambridge, Mass., entered...discovery assay products covered by Ariad's NF-(kappa) B patents...such deals with Ariad. o Biomira Inc., of Edmonton, Alberta, said...